Global Alpha-1 Lung Disease Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Page: 114
Published Date: 06 Aug 2021
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Alpha-1 Lung Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Alpha-1 Lung Disease size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Alpha-1 Lung Disease market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Alpha-1 Lung Disease market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Augmentation Therapy
Cystic Fibrosis(CF)
Non-CF Bronchiectasis(NCFB)
Other
Market segment by Application, can be divided into
Hospitals
Specialty Clinics
Pharmacies
Others
Market segment by players, this report covers
Pfizer
Baxter
AstraZeneca
Grifols
Teva Pharmaceutical Industries
Boehringer Ingelheim
Kamada Ltd
GlaxoSmithKline
CSL Behring
Takeda
LFB Biomedicaments
Abeona Therapeutics
Biogen
Vertex Pharmaceuticals
Baxalta
Arrowhead Research Corporation
ProBioGen
Chiesi Pharmaceuticals
Kedrion Group
ProMetic Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Alpha-1 Lung Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Alpha-1 Lung Disease, with revenue, gross margin and global market share of Alpha-1 Lung Disease from 2019 to 2021.
Chapter 3, the Alpha-1 Lung Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Alpha-1 Lung Disease market forecast, by regions, indication and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Alpha-1 Lung Disease research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Alpha-1 Lung Disease
1.2 Classification of Alpha-1 Lung Disease by Indication
1.2.1 Overview: Global Alpha-1 Lung Disease Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Alpha-1 Lung Disease Revenue Market Share by Type in 2020
1.2.3 Augmentation Therapy
1.2.4 Cystic Fibrosis(CF)
1.2.5 Non-CF Bronchiectasis(NCFB)
1.2.6 Other
1.3 Global Alpha-1 Lung Disease Market by Application
1.3.1 Overview: Global Alpha-1 Lung Disease Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Global Alpha-1 Lung Disease Market Size & Forecast
1.5 Global Alpha-1 Lung Disease Market Size and Forecast by Region
1.5.1 Global Alpha-1 Lung Disease Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Alpha-1 Lung Disease Market Size by Region, (2016-2021)
1.5.3 North America Alpha-1 Lung Disease Market Size and Prospect (2016-2026)
1.5.4 Europe Alpha-1 Lung Disease Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Alpha-1 Lung Disease Market Size and Prospect (2016-2026)
1.5.6 South America Alpha-1 Lung Disease Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Alpha-1 Lung Disease Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Alpha-1 Lung Disease Market Drivers
1.6.2 Alpha-1 Lung Disease Market Restraints
1.6.3 Alpha-1 Lung Disease Trends Analysis
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Alpha-1 Lung Disease Product and Solutions
2.1.4 Pfizer Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Alpha-1 Lung Disease Product and Solutions
2.2.4 Baxter Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Baxter Recent Developments and Future Plans
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Alpha-1 Lung Disease Product and Solutions
2.3.4 AstraZeneca Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 AstraZeneca Recent Developments and Future Plans
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Alpha-1 Lung Disease Product and Solutions
2.4.4 Grifols Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Grifols Recent Developments and Future Plans
2.5 Teva Pharmaceutical Industries
2.5.1 Teva Pharmaceutical Industries Details
2.5.2 Teva Pharmaceutical Industries Major Business
2.5.3 Teva Pharmaceutical Industries Alpha-1 Lung Disease Product and Solutions
2.5.4 Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Alpha-1 Lung Disease Product and Solutions
2.6.4 Boehringer Ingelheim Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Boehringer Ingelheim Recent Developments and Future Plans
2.7 Kamada Ltd
2.7.1 Kamada Ltd Details
2.7.2 Kamada Ltd Major Business
2.7.3 Kamada Ltd Alpha-1 Lung Disease Product and Solutions
2.7.4 Kamada Ltd Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Kamada Ltd Recent Developments and Future Plans
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Alpha-1 Lung Disease Product and Solutions
2.8.4 GlaxoSmithKline Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GlaxoSmithKline Recent Developments and Future Plans
2.9 CSL Behring
2.9.1 CSL Behring Details
2.9.2 CSL Behring Major Business
2.9.3 CSL Behring Alpha-1 Lung Disease Product and Solutions
2.9.4 CSL Behring Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 CSL Behring Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Alpha-1 Lung Disease Product and Solutions
2.10.4 Takeda Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Takeda Recent Developments and Future Plans
2.11 LFB Biomedicaments
2.11.1 LFB Biomedicaments Details
2.11.2 LFB Biomedicaments Major Business
2.11.3 LFB Biomedicaments Alpha-1 Lung Disease Product and Solutions
2.11.4 LFB Biomedicaments Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 LFB Biomedicaments Recent Developments and Future Plans
2.12 Abeona Therapeutics
2.12.1 Abeona Therapeutics Details
2.12.2 Abeona Therapeutics Major Business
2.12.3 Abeona Therapeutics Alpha-1 Lung Disease Product and Solutions
2.12.4 Abeona Therapeutics Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Abeona Therapeutics Recent Developments and Future Plans
2.13 Biogen
2.13.1 Biogen Details
2.13.2 Biogen Major Business
2.13.3 Biogen Alpha-1 Lung Disease Product and Solutions
2.13.4 Biogen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Biogen Recent Developments and Future Plans
2.14 Vertex Pharmaceuticals
2.14.1 Vertex Pharmaceuticals Details
2.14.2 Vertex Pharmaceuticals Major Business
2.14.3 Vertex Pharmaceuticals Alpha-1 Lung Disease Product and Solutions
2.14.4 Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Vertex Pharmaceuticals Recent Developments and Future Plans
2.15 Baxalta
2.15.1 Baxalta Details
2.15.2 Baxalta Major Business
2.15.3 Baxalta Alpha-1 Lung Disease Product and Solutions
2.15.4 Baxalta Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Baxalta Recent Developments and Future Plans
2.16 Arrowhead Research Corporation
2.16.1 Arrowhead Research Corporation Details
2.16.2 Arrowhead Research Corporation Major Business
2.16.3 Arrowhead Research Corporation Alpha-1 Lung Disease Product and Solutions
2.16.4 Arrowhead Research Corporation Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Arrowhead Research Corporation Recent Developments and Future Plans
2.17 ProBioGen
2.17.1 ProBioGen Details
2.17.2 ProBioGen Major Business
2.17.3 ProBioGen Alpha-1 Lung Disease Product and Solutions
2.17.4 ProBioGen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 ProBioGen Recent Developments and Future Plans
2.18 Chiesi Pharmaceuticals
2.18.1 Chiesi Pharmaceuticals Details
2.18.2 Chiesi Pharmaceuticals Major Business
2.18.3 Chiesi Pharmaceuticals Alpha-1 Lung Disease Product and Solutions
2.18.4 Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Chiesi Pharmaceuticals Recent Developments and Future Plans
2.19 Kedrion Group
2.19.1 Kedrion Group Details
2.19.2 Kedrion Group Major Business
2.19.3 Kedrion Group Alpha-1 Lung Disease Product and Solutions
2.19.4 Kedrion Group Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Kedrion Group Recent Developments and Future Plans
2.20 ProMetic Life Sciences
2.20.1 ProMetic Life Sciences Details
2.20.2 ProMetic Life Sciences Major Business
2.20.3 ProMetic Life Sciences Alpha-1 Lung Disease Product and Solutions
2.20.4 ProMetic Life Sciences Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 ProMetic Life Sciences Recent Developments and Future Plans
3.1 Global Alpha-1 Lung Disease Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Alpha-1 Lung Disease Players Market Share
3.2.2 Top 10 Alpha-1 Lung Disease Players Market Share
3.2.3 Market Competition Trend
3.3 Alpha-1 Lung Disease Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4.1 Global Alpha-1 Lung Disease Revenue and Market Share by Type (2016-2021)
4.2 Global Alpha-1 Lung Disease Market Forecast by Type (2021-2026)
5.1 Global Alpha-1 Lung Disease Revenue Market Share by Application (2016-2021)
5.2 Alpha-1 Lung Disease Market Forecast by Application (2021-2026)
6.1 North America Alpha-1 Lung Disease Revenue by Type (2016-2026)
6.2 North America Alpha-1 Lung Disease Revenue by Application (2016-2026)
6.3 North America Alpha-1 Lung Disease Market Size by Country
6.3.1 North America Alpha-1 Lung Disease Revenue by Country (2016-2026)
6.3.2 United States Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
6.3.3 Canada Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
6.3.4 Mexico Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
7.1 Europe Alpha-1 Lung Disease Revenue by Type (2016-2026)
7.2 Europe Alpha-1 Lung Disease Revenue by Application (2016-2026)
7.3 Europe Alpha-1 Lung Disease Market Size by Country
7.3.1 Europe Alpha-1 Lung Disease Revenue by Country (2016-2026)
7.3.2 Germany Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
7.3.3 France Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
7.3.5 Russia Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
7.3.6 Italy Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
8.1 Asia-Pacific Alpha-1 Lung Disease Revenue by Type (2016-2026)
8.2 Asia-Pacific Alpha-1 Lung Disease Revenue by Application (2016-2026)
8.3 Asia-Pacific Alpha-1 Lung Disease Market Size by Region
8.3.1 Asia-Pacific Alpha-1 Lung Disease Revenue by Region (2016-2026)
8.3.2 China Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
8.3.3 Japan Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
8.3.4 South Korea Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
8.3.5 India Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
8.3.7 Australia Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
9.1 South America Alpha-1 Lung Disease Revenue by Type (2016-2026)
9.2 South America Alpha-1 Lung Disease Revenue by Application (2016-2026)
9.3 South America Alpha-1 Lung Disease Market Size by Country
9.3.1 South America Alpha-1 Lung Disease Revenue by Country (2016-2026)
9.3.2 Brazil Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
9.3.3 Argentina Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
10.1 Middle East & Africa Alpha-1 Lung Disease Revenue by Type (2016-2026)
10.2 Middle East & Africa Alpha-1 Lung Disease Revenue by Application (2016-2026)
10.3 Middle East & Africa Alpha-1 Lung Disease Market Size by Country
10.3.1 Middle East & Africa Alpha-1 Lung Disease Revenue by Country (2016-2026)
10.3.2 Turkey Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
10.3.4 UAE Alpha-1 Lung Disease Market Size and Forecast (2016-2026)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Alpha-1 Lung Disease Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Alpha-1 Lung Disease Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Alpha-1 Lung Disease Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Alpha-1 Lung Disease Revenue (USD Million) by Region (2016-2021)
Table 5. Global Alpha-1 Lung Disease Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Alpha-1 Lung Disease Product and Solutions
Table 9. Pfizer Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Baxter Corporate Information, Head Office, and Major Competitors
Table 11. Baxter Major Business
Table 12. Baxter Alpha-1 Lung Disease Product and Solutions
Table 13. Baxter Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 15. AstraZeneca Major Business
Table 16. AstraZeneca Alpha-1 Lung Disease Product and Solutions
Table 17. AstraZeneca Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Grifols Corporate Information, Head Office, and Major Competitors
Table 19. Grifols Major Business
Table 20. Grifols Alpha-1 Lung Disease Product and Solutions
Table 21. Grifols Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 23. Teva Pharmaceutical Industries Major Business
Table 24. Teva Pharmaceutical Industries Alpha-1 Lung Disease Product and Solutions
Table 25. Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 27. Boehringer Ingelheim Major Business
Table 28. Boehringer Ingelheim Alpha-1 Lung Disease Product and Solutions
Table 29. Boehringer Ingelheim Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Kamada Ltd Corporate Information, Head Office, and Major Competitors
Table 31. Kamada Ltd Major Business
Table 32. Kamada Ltd Alpha-1 Lung Disease Product and Solutions
Table 33. Kamada Ltd Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 35. GlaxoSmithKline Major Business
Table 36. GlaxoSmithKline Alpha-1 Lung Disease Product and Solutions
Table 37. GlaxoSmithKline Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. CSL Behring Corporate Information, Head Office, and Major Competitors
Table 39. CSL Behring Major Business
Table 40. CSL Behring Alpha-1 Lung Disease Product and Solutions
Table 41. CSL Behring Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Takeda Corporate Information, Head Office, and Major Competitors
Table 43. Takeda Major Business
Table 44. Takeda Alpha-1 Lung Disease Product and Solutions
Table 45. Takeda Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. LFB Biomedicaments Corporate Information, Head Office, and Major Competitors
Table 47. LFB Biomedicaments Major Business
Table 48. LFB Biomedicaments Alpha-1 Lung Disease Product and Solutions
Table 49. LFB Biomedicaments Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Abeona Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Abeona Therapeutics Major Business
Table 52. Abeona Therapeutics Alpha-1 Lung Disease Product and Solutions
Table 53. Abeona Therapeutics Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Biogen Corporate Information, Head Office, and Major Competitors
Table 55. Biogen Major Business
Table 56. Biogen Alpha-1 Lung Disease Product and Solutions
Table 57. Biogen Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Vertex Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. Vertex Pharmaceuticals Major Business
Table 60. Vertex Pharmaceuticals Alpha-1 Lung Disease Product and Solutions
Table 61. Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Baxalta Corporate Information, Head Office, and Major Competitors
Table 63. Baxalta Major Business
Table 64. Baxalta Alpha-1 Lung Disease Product and Solutions
Table 65. Baxalta Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Arrowhead Research Corporation Corporate Information, Head Office, and Major Competitors
Table 67. Arrowhead Research Corporation Major Business
Table 68. Arrowhead Research Corporation Alpha-1 Lung Disease Product and Solutions
Table 69. Arrowhead Research Corporation Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. ProBioGen Corporate Information, Head Office, and Major Competitors
Table 71. ProBioGen Major Business
Table 72. ProBioGen Alpha-1 Lung Disease Product and Solutions
Table 73. ProBioGen Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Chiesi Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 75. Chiesi Pharmaceuticals Major Business
Table 76. Chiesi Pharmaceuticals Alpha-1 Lung Disease Product and Solutions
Table 77. Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Kedrion Group Corporate Information, Head Office, and Major Competitors
Table 79. Kedrion Group Major Business
Table 80. Kedrion Group Alpha-1 Lung Disease Product and Solutions
Table 81. Kedrion Group Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. ProMetic Life Sciences Corporate Information, Head Office, and Major Competitors
Table 83. ProMetic Life Sciences Major Business
Table 84. ProMetic Life Sciences Alpha-1 Lung Disease Product and Solutions
Table 85. ProMetic Life Sciences Alpha-1 Lung Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Alpha-1 Lung Disease Revenue (USD Million) by Players (2019-2021)
Table 87. Global Alpha-1 Lung Disease Revenue Share by Players (2019-2021)
Table 88. Breakdown of Alpha-1 Lung Disease by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Alpha-1 Lung Disease Players Head Office, Products and Services Provided
Table 90. Alpha-1 Lung Disease Mergers & Acquisitions in the Past Five Years
Table 91. Alpha-1 Lung Disease New Entrants and Expansion Plans
Table 92. Global Alpha-1 Lung Disease Revenue (USD Million) by Type (2016-2021)
Table 93. Global Alpha-1 Lung Disease Revenue Share by Type (2016-2021)
Table 94. Global Alpha-1 Lung Disease Revenue Forecast by Type (2021-2026)
Table 95. Global Alpha-1 Lung Disease Revenue by Application (2016-2021)
Table 96. Global Alpha-1 Lung Disease Revenue Forecast by Application (2021-2026)
Table 97. North America Alpha-1 Lung Disease Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Alpha-1 Lung Disease Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Alpha-1 Lung Disease Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Alpha-1 Lung Disease Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Alpha-1 Lung Disease Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Alpha-1 Lung Disease Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Alpha-1 Lung Disease Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Alpha-1 Lung Disease Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Alpha-1 Lung Disease Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Alpha-1 Lung Disease Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Alpha-1 Lung Disease Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Alpha-1 Lung Disease Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Alpha-1 Lung Disease Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Alpha-1 Lung Disease Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Alpha-1 Lung Disease Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Alpha-1 Lung Disease Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Alpha-1 Lung Disease Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Alpha-1 Lung Disease Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Alpha-1 Lung Disease Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Alpha-1 Lung Disease Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Alpha-1 Lung Disease Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Alpha-1 Lung Disease Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Alpha-1 Lung Disease Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Alpha-1 Lung Disease Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Alpha-1 Lung Disease Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Alpha-1 Lung Disease Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Alpha-1 Lung Disease Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Alpha-1 Lung Disease Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Alpha-1 Lung Disease Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Alpha-1 Lung Disease Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Alpha-1 Lung Disease Picture
Figure 2. Global Alpha-1 Lung Disease Revenue Market Share by Indication in 2020
Figure 3. Augmentation Therapy
Figure 4. Cystic Fibrosis(CF)
Figure 5. Non-CF Bronchiectasis(NCFB)
Figure 6. Other
Figure 7. Alpha-1 Lung Disease Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Specialty Clinics Picture
Figure 10. Pharmacies Picture
Figure 11. Others Picture
Figure 12. Global Alpha-1 Lung Disease Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Alpha-1 Lung Disease Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Alpha-1 Lung Disease Revenue Market Share by Region (2016-2026)
Figure 15. Global Alpha-1 Lung Disease Revenue Market Share by Region in 2020
Figure 16. North America Alpha-1 Lung Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Alpha-1 Lung Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Alpha-1 Lung Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Alpha-1 Lung Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Alpha-1 Lung Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Alpha-1 Lung Disease Market Drivers
Figure 22. Alpha-1 Lung Disease Market Restraints
Figure 23. Alpha-1 Lung Disease Market Trends
Figure 24. Pfizer Recent Developments and Future Plans
Figure 25. Baxter Recent Developments and Future Plans
Figure 26. AstraZeneca Recent Developments and Future Plans
Figure 27. Grifols Recent Developments and Future Plans
Figure 28. Teva Pharmaceutical Industries Recent Developments and Future Plans
Figure 29. Boehringer Ingelheim Recent Developments and Future Plans
Figure 30. Kamada Ltd Recent Developments and Future Plans
Figure 31. GlaxoSmithKline Recent Developments and Future Plans
Figure 32. CSL Behring Recent Developments and Future Plans
Figure 33. Takeda Recent Developments and Future Plans
Figure 34. LFB Biomedicaments Recent Developments and Future Plans
Figure 35. Abeona Therapeutics Recent Developments and Future Plans
Figure 36. Biogen Recent Developments and Future Plans
Figure 37. Vertex Pharmaceuticals Recent Developments and Future Plans
Figure 38. Baxalta Recent Developments and Future Plans
Figure 39. Arrowhead Research Corporation Recent Developments and Future Plans
Figure 40. ProBioGen Recent Developments and Future Plans
Figure 41. Chiesi Pharmaceuticals Recent Developments and Future Plans
Figure 42. Kedrion Group Recent Developments and Future Plans
Figure 43. ProMetic Life Sciences Recent Developments and Future Plans
Figure 44. Global Alpha-1 Lung Disease Revenue Share by Players in 2020
Figure 45. Alpha-1 Lung Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 46. Global Top 3 Players Alpha-1 Lung Disease Revenue Market Share in 2020
Figure 47. Global Top 10 Players Alpha-1 Lung Disease Revenue Market Share in 2020
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 49. Global Alpha-1 Lung Disease Revenue Share by Type in 2020
Figure 50. Global Alpha-1 Lung Disease Market Share Forecast by Type (2021-2026)
Figure 51. Global Alpha-1 Lung Disease Revenue Share by Application in 2020
Figure 52. Global Alpha-1 Lung Disease Market Share Forecast by Application (2021-2026)
Figure 53. North America Alpha-1 Lung Disease Sales Market Share by Type (2016-2026)
Figure 54. North America Alpha-1 Lung Disease Sales Market Share by Application (2016-2026)
Figure 55. North America Alpha-1 Lung Disease Revenue Market Share by Country (2016-2026)
Figure 56. United States Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Canada Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Mexico Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Europe Alpha-1 Lung Disease Sales Market Share by Type (2016-2026)
Figure 60. Europe Alpha-1 Lung Disease Sales Market Share by Application (2016-2026)
Figure 61. Europe Alpha-1 Lung Disease Revenue Market Share by Country (2016-2026)
Figure 62. Germany Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. France Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. United Kingdom Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Russia Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Italy Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Asia-Pacific Alpha-1 Lung Disease Sales Market Share by Type (2016-2026)
Figure 68. Asia-Pacific Alpha-1 Lung Disease Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Alpha-1 Lung Disease Revenue Market Share by Region (2016-2026)
Figure 70. China Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Japan Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South Korea Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. India Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Southeast Asia Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Australia Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South America Alpha-1 Lung Disease Sales Market Share by Type (2016-2026)
Figure 77. South America Alpha-1 Lung Disease Sales Market Share by Application (2016-2026)
Figure 78. South America Alpha-1 Lung Disease Revenue Market Share by Country (2016-2026)
Figure 79. Brazil Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Argentina Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Middle East and Africa Alpha-1 Lung Disease Sales Market Share by Type (2016-2026)
Figure 82. Middle East and Africa Alpha-1 Lung Disease Sales Market Share by Application (2016-2026)
Figure 83. Middle East and Africa Alpha-1 Lung Disease Revenue Market Share by Country (2016-2026)
Figure 84. Turkey Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Saudi Arabia Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. UAE Alpha-1 Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Pfizer Baxter AstraZeneca Grifols Teva Pharmaceutical Industries Boehringer Ingelheim Kamada Ltd GlaxoSmithKline CSL Behring Takeda LFB Biomedicaments Abeona Therapeutics Biogen Vertex Pharmaceuticals Baxalta Arrowhead Research Corporation ProBioGen Chiesi Pharmaceuticals Kedrion Group ProMetic Life Sciences
19 Jan 2022
Pharma & Healthcare
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
